Page 338 - TBE_Book_V2_2019

Chapter 12b: TBE in Lithuania

of 9,082 TBE cases was reported between with TBEV in Lithuania; 56.4% of TBE patients
11
1993 and 2015. Retired and unemployed are infected in the immediate areas surround-
12
people are the major risk group for infection ing their homes.

Overview of TBE in Lithuania

Table 1: Virus, vector, transmission of TBE in Lithuania

5,7
Viral subtypes, distribution European TBEV subtype

Main reservoir animals –
Reservoir animals Apodemus agrarius,
Apodemus flavicollis, Myodes glareolus 13

Infected tick species (%) I. ricinus (0.1–1.7%) 5
11
Dairy product transmission Rare

Table 2: TBE reporting and vaccine prevention in Lithuania

All hospitalized patients with CNS form of TBEV infection confirmed
Mandatory TBE reporting by serological methods (TBEV IgM ± IgG) are reported to the
11
Lithuanian Center for Communicable Diseases and AIDS
Other TBE surveillance N/A

Biphasic disease in 72.2%
Risk groups: retired people, unemployed people, and permanent
Special clinical features 12
inhabitants of highly endemic areas
12
Moderate and severe sequelae in 30.8%. Mortality 0.75%
11
Encepur, Ticovac
Available vaccines
Total number of doses sold 2010–2015: 308, 969
Vaccination of adults: the joint recommendations by Lithuanian
Vaccination
Societies for Infectious Diseases, Internal and Family Medicine (2013;
recommendations and no reimbursement). Reimbursed for military recruits and forestry
reimbursement
workers*
11
Vaccine uptake by age Total number of doses sold 2010-2015:
group/risk group/general Children (0–17 years) – 101, 651
population Adults (>18 years) – 207, 318

Name, address/website of 11
The Lithuanian Center for Communicable Diseases and AIDS
TBE NRC

333